Avacincaptad pegol, sold under the brand name Izervay, is a medication used for the treatment of age-related macular degeneration.[1] Avacincaptad pegol is a complement inhibitor.[1]
Avacincaptad pegol was approved for medical use in the United States in August 2023.[2][3][4]
Avacincaptad pegol is indicated for the treatment of geographic atrophy secondary to age-related macular degeneration.[5]
Avacincaptad pegol is the international nonproprietary name.[6]
This pharmacology-related article is a stub. You can help Wikipedia by expanding it.
Lokasi Pengunjung: 18.117.138.193